R-4-amino-3-(4-chlorophenyl)butanoic acid

R-4-amino-3-(4-chlorophenyl)butanoic acid
Trade Name
Orphan Indication Fragile X syndrome
USA Market Approval USA
USA Designation Date 2008-11-28 00:00:00
Sponsor Clinical Research Associates, LLC;160 Fifth Avenue, 7th Floor;New York, New York, 10010